Brief: Bone Therapeutics To Present Data At TERMIS European Chapter Meeting 2019

Biosenic SA

24/05/2019 06:36

May 24 (Reuters) - Bone Therapeutics SA  BOTHE.BR :
    * TO PRESENT PRECLINICAL IN VITRO AND IN VIVO RESULTS
HIGHLIGHTING
POTENT OSTEOGENIC PROPERTIES OF CO'S INJECTABLE ALLOGENEIC
BONE-FORMING CELL THERAPY PRODUCT TO PROMOTE BONE REGENERATION
AND IMPROVE FRACTURE HEALING IN RELEVANT ANIMAL MODELS

Source text for Eikon:  ID:nGNE1v8QYK 
Further company coverage:  BOTHE.BR 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))